← Companies|Travere Ther
TV

Travere Ther

TVTX·NASDAQSan Diego CAFounded 2003350 employees
Small CapbiotechPublicNephrologyRare Disease
Platform: Sparsentan IgAN
Market Cap
$1.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (TVTX)
Loading TVTX stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
TVT-9611TVT-9611NDA/BLA1Gene TherapyWEE1BETiNarcolepsy
VoxafutibatinibTVT-2515Phase 12ASOTYK2PLK4iSMAMigraine
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)
2025-07-13
Voxafutibatinib Interim
CSU
Past
2029-02-02
TVT-9611 Ph3 Readout
Narcolepsy
Ph3 Readout
2030-03-25
Voxafutibatinib Interim
Migraine
Interim